Entrada Therapeutics, Inc. is a biotechnology organisation focused on the development of treatments for severe diseases. The company operates worldwide, primarily in biotechnology and medical research.
Contributing to the biotechnology sector, Entrada Therapeutics provides services in the field of protein and peptide therapies. Its therapy approach seeks to address challenging diseases, with a key focus on patients suffering from untreatable issues. The company also collaborates with partners in the industry to fuel its research.
Keep an eye on the price movements of TRDA stock by adding it to your eToro watchlist.